Education
About Us
Working with TipRanks
Follow Us
Harshad Angel - New Portfolio
HARSHAD SOLANKI
Harshad AngelIndividual Investor
Not Ranked
Ranked #― out of 1 TipRanks' Investors
Success Rate
121 out of 175
profitable transactions
profitable transactions
Average Return
63.25%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 12.66%
6-Month Return▲ 112.67%
12-Month Return▲ 61.08%
YTD Return▲ 38.91%
Total Return▲ 73.10%
Best Trade
Bio
Managing my funds for maximum returns
Performance
36.14%0-36.14%
▲ 1.65%
▼ 1.27%
▼ 17.90%
Feb 2025
▼ 4.94%
▼ 5.57%
▼ 14.96%
Mar 2025
▲ 1.11%
▼ 0.87%
▲ 9.30%
Apr 2025
▲ 14.06%
▲ 6.28%
▲ 15.91%
May 2025
▲ 10.82%
▲ 5.14%
▲ 8.91%
Jun 2025
▲ 7.00%
▲ 2.30%
▲ 36.14%
Jul 2025
▲ 2.23%
▲ 2.05%
▲ 2.74%
Aug 2025
▲ 11.44%
▲ 2.88%
▲ 14.87%
Sep 2025
▲ 1.65%▼ 1.27%▼ 17.90%
▼ 4.94%▼ 5.57%▼ 14.96%
▲ 1.11%▼ 0.87%▲ 9.30%
▲ 14.06%▲ 6.28%▲ 15.91%
▲ 10.82%▲ 5.14%▲ 8.91%
▲ 7.00%▲ 2.30%▲ 36.14%
▲ 2.23%▲ 2.05%▲ 2.74%
▲ 11.44%▲ 2.88%▲ 14.87%
Recent Activity
International Business Machines
0%
0.00%
1
Open
Sep 26, 2025
Alphabet Class A
0%
▲ 49.04%
11
Sell
Sep 15, 2025
BioCryst
65.11%
▲ 3.03%
22
Buy
Sep 13, 2025
Apple
21.32%
▲ 24.26%
6
Sell
Sep 04, 2025
Atara Biotherapeutics
0.57%
▲ 27.27%
16
Sell
Aug 22, 2025
Rigetti Computing
0.65%
▲ 95.12%
1
Open
Aug 10, 2025
TScan Therapeutics
1.54%
▼ 12.52%
17
Buy
Aug 08, 2025
Novavax
0%
▲ 17.37%
4
Buy
Aug 08, 2025
BitMine Immersion Technologies
0%
▲ 62.22%
2
Sell
Aug 08, 2025
Amazon
4.59%
▲ 20.01%
7
Buy
Aug 04, 2025
Plug Power
0.2%
▲ 33.04%
22
Buy
Aug 04, 2025
Agenus
0.25%
▲ 13.94%
15
Buy
Aug 04, 2025
Taysha Gene Therapies
0.14%
▲ 44.10%
14
Buy
Aug 04, 2025
Oncolytics Biotech
0.13%
▲ 79.67%
4
Buy
Aug 04, 2025
Viking Therapeutics
1.6%
▼ 15.90%
10
Buy
Aug 04, 2025
Arbe Robotics
0.43%
▲ 23.30%
5
Buy
Aug 04, 2025
Lumen Technologies
0.37%
▲ 53.60%
3
Buy
Aug 04, 2025
Praxis Precision Medicines
2.19%
▲ 25.39%
4
Buy
Aug 04, 2025
Serve Robotics Inc
0.24%
▲ 45.33%
3
Buy
Aug 04, 2025
Patriot Battery Metals Inc
0%
▲ 45.60%
3
Sell
Aug 04, 2025